Jefferies Initiates Coverage On Abivax with Buy Rating, Announces Price Target of $160

Benzinga Newsdesk www.benzinga.com Neutral 59.0%

Neg 0% Neu 59% Pos 0%

Jefferies analyst Faisal Khurshid initiates coverage on Abivax (NASDAQ:ABVX) with a Buy rating and announces Price Target of $160.